What is the Purpose of this Study?
Determine if early treatment with dronedarone is superior to usual care for the prevention of cardiovascular hospitalization or death from any cause in patients with first-detected atrial fibrillation.
Eligibility
- Age >=21 years.
- First-detected atrial fibrillation (defined as atrial fibrillation diagnosed in the previous 120 days).
- Electrocardiographic documentation of atrial fibrillation.
- Estimated life expectancy of at least 1 year.
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
Pragmatic Randomized Clinical Trial of Early Dronedarone versus Usual Care to Change and Improve Outcomes in Persons with First-Detected Atrial Fibrillation